| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. White and Shaw) and Human Genetics (Drs. White, Bashir, and Bushby, and M. Lusher and J. Lindsey), University of Newcastle upon Tyne; and MRC Neurochemical Pathology Unit (Drs. Ince and Cookson), Newcastle General Hospital, Newcastle upon Tyne, UK.
Address correspondence and reprint requests to Dr. K.M.D. Bushby, Department of Human Genetics, 19/20 Claremont Place, Newcastle upon Tyne NE2 4AA, UK; e-mail: kate.bushby{at}ncl.ac.uk
OBJECTIVE: To describe a family with chromosome 2p-linked hereditary spastic paraparesis (HSP) associated with dementia and illustrate the cerebral pathology associated with this disorder.
BACKGROUND: HSP comprises a heterogeneous group of inherited disorders in which the main clinical feature is severe, progressive lower limb spasticity. Nongenetic classification relies on characteristics such as mode of inheritance, age at onset, and the presence or absence of additional neurologic features. Several loci have been identified for autosomal dominant pure HSP. The most common form, which links to chromosome 2p (SPG4), has recently been shown to be due to mutations in spastin, the gene encoding a novel AAA-containing protein.
RESULTS: The authors report four generations of a British family with autosomal dominant HSP in whom haplotype analysis indicates linkage to chromosome 2p. In addition, a missense mutation has been identified in exon 10 of the spastin gene (A1395G). Dementia was documented clinically in one member of the family, two other affected family members were reported to have had late onset memory loss, and a younger affected individual showed evidence of memory disturbance and learning difficulties. Autopsy of the demented patient confirmed changes in the spinal cord typical of HSP and also demonstrated specific cortical pathology. There was neuronal depletion and tau-immunoreactive neurofibrillary tangles in the hippocampus and tau-immunoreactive balloon cells were seen in the limbic and neocortex. The substantia nigra showed Lewy body formation. The pathologic findings are not typical of known tauopathies.
CONCLUSIONS: The authors confirm that chromosome 2p-linked HSP can be associated with dementia and that this phenotype may be associated with a specific and unusual cortical pathology.
This article has been cited by other articles:
|
|
 |
|
  F. Brugman, H. Scheffer, J.H.J. Wokke, W. M. Nillesen, M. de Visser, E. Aronica, J. H. Veldink, and L. H. van den Berg Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes Neurology, November 4, 2008; 71(19): 1500 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. McDermott, C. E. Burness, J. Kirby, L. E. Cox, D. G. Rao, C. Hewamadduma, B. Sharrack, M. Hadjivassiliou, P. F. Chinnery, A. Dalton, et al. Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology, July 11, 2006; 67(1): 45 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. McMonagle, P. Byrne, and M. Hutchinson Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia Neurology, February 10, 2004; 62(3): 407 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Bonsch, A Schwindt, P Navratil, D Palm, C Neumann, S Klimpe, J Schickel, J Hazan, C Weiller, T Deufel, et al. Motor system abnormalities in hereditary spastic paraparesis type 4 (SPG4) depend on the type of mutation in the spastin gene J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1109 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. E. Tallaksen, E. Guichart-Gomez, P. Verpillat, V. Hahn-Barma, M. Ruberg, B. Fontaine, A. Brice, B. Dubois, and A. Durr Subtle Cognitive Impairment but No Dementia in Patients With Spastin Mutations Arch Neurol, August 1, 2003; 60(8): 1113 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schulte, B. Miterski, C. Bornke, H. Przuntek, J. T. Epplen, and L. Schols Neurophysiological findings in SPG4 patients differ from other types of spastic paraplegia Neurology, May 13, 2003; 60(9): 1529 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Errico, A. Ballabio, and E. I. Rugarli Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics Hum. Mol. Genet., January 1, 2002; 11(2): 153 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S H Mead, C Proukakis, N Wood, A H Crosby, G T Plant, and T T Warner A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(6): 788 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.J. Higgins, J.M. Loveless, S. Goswami, L.E. Nee, C. Cozzo, A. De Biase, and D.R. Rosen An atypical intronic deletion widens the spectrum of mutations in hereditary spastic paraplegia Neurology, June 12, 2001; 56(11): 1482 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mc Monagle, P. Byrne, T. Burke, N. Parfrey, and M. Hutchinson Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation Neurology, January 9, 2001; 56(1): 139 - 139. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
